New scan tested to better see prostate cancer
NCT ID NCT03995888
Summary
This early-stage study tested a new imaging agent called rhPSMA-7.3 (18F) injection. The main goals were to check its safety, see how it moves through the body, and understand how well it can create pictures of prostate cancer. The study involved a small group of healthy volunteers and men with prostate cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Services Turku - CRST Oy
Turku, FI-20520, Finland
Conditions
Explore the condition pages connected to this study.